A summary of IPOs from companies in the biotech and pharma world since January 1, 2019.
January 2019 IPO Filings and Pricings, Updated 1/31/19
Know of an IPO since Jan. 1, 2019 that we missed? Email us at news@biospace.com.
Related: Check out BioSpace’s October list, November list, and December list.
| Date | Company Name | Amount (USD) | Company HQ | Research Focus |
|---|---|---|---|---|
| 1/29/19 | Bionexus Gene Lab Corporation | $0.52M Filed | Wyoming | Blood tests using functional genomics for early diagnosis |
| 1/23/19 | Gossamer Bio | $230M Priced | San Diego, CA | Therapeutics in the disease areas of immunology, inflammation, and oncology |
| 1/18/19 | Avedro | $86M Filed | Waltham, MA | Technology for corneal ectatic disorders and refractive conditions |
| 1/14/19 | Brainsway | $30M Filed | Jerusalem, Israel | Deep TMS technology for the treatment of MDD and OCD |
| 1/11/19 | Cirius Therapeutics | $86M Filed | San Diego, CA | Innovative therapies for the treatment of liver and metabolic diseases |
| 1/11/19 | Kaleido Biosciences | $100M Filed | Lexington, MA | Modulate the metabolic output and profile of the body’s microbiome |
| 1/7/19 | Alector | $150M Filed | San Francisco, CA | Develop therapies that empower the immune system to cure neurodegeneration |
| 1/7/19 | Anchiano Therapeutics | $35M Filed | Jerusalem, Israel | Genetic therapy for early-stage bladder cancer |
| 1/4/19 | Poseida Therapeutics | $115M Priced | San Diego, CA | CAR-T products to treat hematological malignancies and solid tumors |
| 1/4/19 | China SXT Pharmaceuticals | $10.2M Priced | Taizhou, China | Research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces |
